Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study-Reference-Cited by-同舟云学术

Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study

Published:2010-01 Issue:1 Volume:72 Page:53-58
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Nachtigall Lisa B.,Valassi Elena,Lo Janet,McCarty David,Passeri Jonathan,Biller Beverly M. K.,Miller Karen K.,Utz Andrea,Grinspoon Steven,Lawson Elizabeth A.,Klibanski Anne

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2009.03608.x/fullpdf

Reference20 articles.

1. Dopamine agonists and the risk of cardiac-valve regurgitation;Schade;New England Journal of Medicine,2007

2. Valvular heart disease and the use of dopamine agonists for Parkinsonâs disease;Zanettini;New England Journal of Medicine,2007

3. Drugs and valvular heart disease;Roth;New England Journal of Medicine,2007

4. Cabergoline and the risk of valvular lesions in endocrine disease;Lancellotti;European Journal of Endocrinology,2008

5. Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia;Bogazzi;International Journal of Clinical Practice,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the Patient With Prolactinoma;The Journal of Clinical Endocrinology & Metabolism;2023-03-28

2. Hyperprolactinemia;Endocrinology and Diabetes;2022

3. Prolactinomas: Diagnosis and medical treatment;Pituitary Tumors;2021

4. Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints;The Journal of Clinical Endocrinology & Metabolism;2020-11-28

5. Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study;BMC Endocrine Disorders;2020-02-19